Skip to main content
Signal8

Guardant Health, Inc. (GH)

Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (available in LDT and CDx versions) and GuardantOMNI. Complementing these diagnostic tools, Guardant Health also provides GuardantINFORM, an in-silico research platform leveraging an extensive clinical-genomic liquid biopsy dataset derived from advanced cancer patients. Innovation is a key focus, with the company currently developing the LUNAR-2 test, designed for the early detection of colorectal cancer in eligible asymptomatic individuals. Another emerging solution in development is GuardantConnect, an integrated software platform intended to link biopharmaceutical and clinical clients by connecting patients whose Guardant360 tests reveal actionable alterations with potentially relevant clinical trials. Furthermore, Guardant Health offers the Guardant Reveal Test, which aids in selecting neoadjuvant and adjuvant treatments for early-stage cancer patients. Its portfolio also includes a Guardant360 product for tissue genotyping and Guardant-19 for novel coronavirus detection. The company extends its expertise to biopharmaceutical companies and medical institutions through various development services, encompassing companion diagnostic development, regulatory approval support, clinical study management (including setup, monitoring, and maintenance), testing development, and kit fulfillment.

Sector: Services-Medical Laboratories

Industry: Medical - Diagnostics & Research

Guardant Health, Inc. logo

Guardant Health, Inc.

NASDAQ:GHHealthcare
-3.51%$178.80
AH$178.00-0.45%vs close
Mkt Cap$23.99B
Float126.96M
O/S134.2M
Vol
$ Vol
RVOL
Inst Own99.8%
SI9.2%
Earnings
Dilution
Financials Summary
Revenue$982.02M
Net Income-$416.28M
Total Assets$2.01B
Free Cash Flow-$233.07M
Debt & Equity
Debt 106%
Total Debt$1.71B
Total Equity-$99.31M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in GH's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$2.01B
Liabilities$2.11B
Accounts Receivable$137.85M
Accounts Payable$54.44M
Inventory$85.88M
PP&E (Net)$304.76M
Goodwill$77.26M
Intangible Assets$25.92M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$982.02M$739.02M$563.95M$449.54M$373.65M$286.73M$214.38M$90.64M$49.84M$25.25M
YoY Growth32.9%31.0%25.5%20.3%30.3%33.8%136.5%81.9%97.4%-
Cost of Revenue$349.01M$289.8M$227.05M$156.32M$122.91M$92.53M$70.72M$43.21M$31.62M$22.12M
Gross Profit$633.01M$449.22M$336.9M$293.21M$250.74M$194.19M$143.66M$47.43M$18.22M$3.13M
Gross Margin64.5%60.8%59.7%65.2%67.1%67.7%67.0%52.3%36.6%12.4%
Research and Development$364.19M$347.75M$367.19M$373.81M$263.22M$149.86M$86.29M$50.71M$25.56M$10.86M
Selling, General, and Administrative$706.07M$545.06M$451.03M$463.78M$398.52M$299.28M$139.73M$89.66M$69.27M$36.11M
Other$0$0$83.4M$0$0$0$88K$0$0-$1K
Total Operating Expenses$1.07B$892.81M$901.62M$837.59M$661.74M$449.14M$226.03M$140.37M$94.84M$46.97M
Operating Income (EBIT)-$437.25M-$443.59M-$564.73M-$544.38M-$411M-$254.95M-$82.37M-$92.94M-$76.61M-$43.85M
Operating Margin-44.5%-60.0%-100.1%-121.1%-110.0%-88.9%-38.4%-102.5%-153.7%-173.7%
Interest Expense$3.9M$2.58M$2.58M$2.58M$2.58M$4.77M$1.18M$1.25M$2.7M$3.02M
Interest Income$34.09M$53.69M$35.37M$6.07M$3.93M$10.17M$13.74M$5.27M$2.23M$733K
Other Income (Expense)$19.71M$8.51M$85.96M-$109.07M$26.53M$9.05M$12.65M$8.72M-$6.6M-$2.29M
Income Before Tax (EBT)-$417.54M-$435.09M-$478.76M-$653.45M-$384.47M-$245.9M-$69.72M-$84.22M-$83.21M-$46.13M
Income Tax Expense-$1.26M$1.28M$685K$1.14M$300K$379K-$1.87M$38K$7K$6K
Net Income-$416.28M-$436.37M-$479.45M-$654.59M-$405.67M-$253.78M-$75.65M-$85.06M-$83.22M-$46.14M
Net Income Margin-42.4%-59.0%-85.0%-145.6%-108.6%-88.5%-35.3%-93.8%-167.0%-182.7%
Supplementary Data
EPS-3.32-3.56-4.28-6.41-4.00-2.53-0.75-1.00-1.18-3.49
Diluted EPS-3.32-3.56-4.28-6.41-4.00-2.53-0.75-1.00-1.18-3.49
Weighted Average OS125.37M122.75M111.99M102.18M101.31M97.50M90.60M85.03M70.72M13.22M
EBITDA-$373.91M-$390.12M-$433.31M-$614.91M-$359.62M-$225.07M-$57.13M-$75.84M-$75.31M-$39.42M
EBITDA Margin-38.1%-52.8%-76.8%-136.8%-96.2%-78.5%-26.7%-83.7%-151.1%-156.1%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Assets
Current Assets
Cash and Cash Equivalents$378.2M$525.54M$1.13B$141.65M$492.2M$832.98M$143.23M$140.54M$72.28M$33.59M
Short-Term Investments$823.39M$314.44M$35.1M$869.58M$440.55M$961.9M$379.57M$278.42M$149.04M$61.66M
Cash and Short-Term Investments$1.2B$839.98M$1.17B$1.01B$932.75M$1.79B$522.8M$418.96M$221.32M$95.26M
Accounts Receivable$137.85M$110.25M$88.78M$97.26M$97.65M$53.3M$47.99M$35.69M$12.79M$3.5M
Inventory$85.88M$71.08M$61.95M$51.6M$30.67M$22.72M$15.18M$9.14M$7.29M$2.77M
Other Current Assets$40.72M$33.8M$27.74M$31.51M$0$0$0$0$0$0
Total Current Assets$1.47B$1.06B$1.35B$1.19B$1.11B$1.89B$597.36M$468.99M$242.94M$103.09M
Long-Term Assets
Property, Plant & Equipment Net$304.76M$279.08M$302.71M$341.92M$313.9M$100.13M$72.81M$31M$16.04M$12.63M
Goodwill$77.26M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$0$0$0
Intangible Assets$25.92M$6.76M$8.98M$11.73M$14.21M$16.16M$15.41M$7.8M$8.74M$0
Long-Term Investments$0$0$0$0$698.03M$246.6M$268.78M$77.56M$73.25M$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$139.67M$141.37M$124.33M$61.45M$60.94M$17.25M$4.88M$2.05M$1.97M$840K
Total Long-Term Assets$547.61M$430.5M$439.31M$418.39M$1.09B$383.42M$365.18M$118.41M$100M$13.47M
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Assets$2.01B$1.49B$1.79B$1.61B$2.2B$2.27B$962.53M$587.4M$342.94M$116.56M
Liabilities
Current Liabilities
Accounts Payable$54.44M$38.55M$51.74M$68.91M$38.52M$7.34M$16.2M$10.64M$5M$3.16M
Short-Term Debt$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$4.22M$4.63M$3.05M$1.47M$905K$345K
Current Unearned Revenue$50.75M$35.47M$17.96M$17.4M$11.33M$8.55M$12.28M$16.14M$3.11M$1.9M
Other Current Liabilities$119.65M$83.22M$72.74M$55.79M$120.5M$28.28M$18.56M$12.99M$4.91M$7.3M
Total Current Liabilities$302.73M$225.58M$205.92M$193.22M$194.69M$66.81M$72.73M$46.94M$19.63M$14.28M
Long-Term Liabilities
Long-Term Debt$1.5B$1.14B$1.14B$1.14B$1.13B$806.29M$0$0$0$16.48M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$127.77M$92.83M$96.01M$9.18M$3.93M$1.52M$8.55M$15.51M$14.24M$5.68M
Total Long-Term Liabilities$1.81B$1.4B$1.42B$1.36B$1.36B$849.38M$41.81M$15.51M$14.71M$22.59M
Other Liabilities$0$0$0$0$0$0$0$0$0$0
Total Liabilities$2.11B$1.63B$1.63B$1.55B$1.56B$916.19M$114.54M$62.45M$34.33M$36.87M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$499.97M$180M
Common Stock$1K$1K$1K$1K$1K$1K$1K$1K$0$0
Retained Earnings-$2.99B-$2.58B-$2.14B-$1.66B-$1.01B-$606.59M-$352.81M-$280.8M-$195.74M-$107.63M
Comprehensive Income & Other-$4.85M-$5.2M-$3.67M-$19.52M-$4.76M$2.7M$1.11M-$83K-$532K-$86K
Other Stockholders' Equity$2.9B$2.44B$2.3B$1.72B$1.65B$1.91B$1.15B$763.95M$504.34M$187.32M
Total Equity-$99.31M-$139.65M$158.68M$60.18M$645M$1.3B$798.39M$483.15M$308.61M$79.7M
Minority Interest$0$0$0$0$0$57.1M$49.6M$41.8M$0$0
Total Liabilities and Equity$2.01B$1.49B$1.79B$1.61B$2.2B$2.21B$912.93M$545.6M$342.94M$116.56M
Supplementary Data
Total Debt$1.71B$1.34B$1.35B$1.37B$1.37B$854.49M$40.4M$0$659K$17.04M
Net Debt$1.33B$810.51M$220.23M$1.23B$881.53M$21.51M-$102.83M-$140.54M-$71.62M-$16.55M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating Activities
Net Income-$416.28M-$436.37M-$479.45M-$654.59M-$384.77M-$246.28M-$67.85M-$84.26M-$83.22M-$46.14M
Depreciation & Amortization$39.74M$42.39M$42.88M$35.96M$22.27M$16.07M$11.41M$7.14M$5.21M$3.69M
Deferred Income Tax$0$0$0$0$0$0-$1.6M$0$0$0
Stock-Based Compensation$166.22M$140.41M$90.76M$94.69M$151.45M$144.11M$16.95M$6.85M$3.67M$1.97M
Changes in Working Capital:
  Accounts Receivable-$28.18M-$21.39M$8.38M$375K-$44.35M-$5.46M-$7.39M-$22.9M-$9.29M-$2.79M
  Inventory-$14.79M-$9.13M-$10.35M-$20.93M-$7.96M-$7.54M-$6.04M-$1.85M-$4.52M-$351K
  Accounts Payable$0$0$0$60.33M$8.64M-$7.86M$4.34M$5.05M$1.25M$2.15M
  Other Working Capital$28.54M-$30.34M$55.81M$21.79M$3.2M-$26.81M$790K$18.58M$7.57M$3.45M
Total Working Capital Change-$14.43M-$60.86M$53.84M$61.56M-$40.47M-$47.66M-$8.3M-$1.13M-$4.99M$2.45M
Other Non-Cash Items$39.99M$74.58M-$33.01M$152.91M$42.5M$29.84M$2.25M-$782K$7.1M$1.31M
Net Cash from Operating-$184.76M-$239.86M-$324.98M-$309.46M-$209.02M-$103.93M-$47.13M-$72.19M-$72.23M-$36.71M
Investing Activities
Capital Expenditures-$48.31M-$35.09M-$20.49M-$77.46M-$75.03M-$36.17M-$18.72M-$20.2M-$6.68M-$1.77M
Acquisitions-$58.99M$0$0$0$0$0-$7.33M$0$0$0
Purchases of Investments-$827.23M-$314.82M-$635.5M-$327.72M-$940.23M-$1.13B-$614.29M-$287.45M-$236.84M-$341.42M
Sales of Investments$307.32M$88.6M$1.5B$555M$952.11M$562.55M$325.33M$154.63M$75.4M$369.38M
Other Investing Activities$0$0$0$0$0-$17.89M-$2.57M$0-$2.3M$0
Net Cash from Investing-$627.2M-$261.31M$840.25M$149.82M-$63.16M-$617.09M-$317.57M-$153.03M-$170.42M$26.2M
Financing Activities
Debt Repaid-$402.5M--$71K$146K-$1.13B$438K$443K$26.09M$375K
Common Stock Issuance$377.81M$14.84M$493.12M$0$0$355.73M$350.43M$254.01M$0$0
Common Stock Repurchases-$45.01M$0$0$0$0$0$0-$172K-$7.22M-$100K
Dividends Paid$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$64.17M-$15.83M-$15.74M-$189.02M-$66.68M-$78M$17.31M$39.77M$765K$266K
Net Cash from Financing$671.13M-$996K$477.38M-$189.09M-$66.82M$1.41B$367.3M$293.16M$281.66M$39.84M
Forex Effect$491K-$1.77M-$911K-$1.6M-$1.69M$455K$84K$0$0$0
Net Change in Cash-$140.34M-$503.93M$991.74M-$350.34M-$340.69M$689.75M$2.68M$67.95M$39.01M$29.33M
Supplementary Data
Operating Cash Flow-$184.76M-$239.86M-$324.98M-$309.46M-$209.02M-$103.93M-$47.13M-$72.19M-$72.23M-$36.71M
Capital Expenditure-$48.31M-$35.09M-$20.49M-$77.46M-$75.03M-$54.06M-$21.29M-$20.2M-$8.98M-$1.77M
Free Cash Flow-$233.07M-$274.94M-$345.46M-$386.92M-$284.05M-$157.99M-$68.42M-$92.39M-$81.22M-$38.48M
Cash at Beginning$629.75M$1.13B$141.95M$492.29M$832.98M$143.23M$140.54M$72.6M$33.59M$4.26M
Cash at End$489.42M$629.75M$1.13B$141.95M$492.29M$832.98M$143.23M$140.54M$72.6M$33.59M